Any feedback?
Literature summary extracted from
- Clinical pharmacokinetics of irinotecan (1997), Clin. Pharmacokinet., 33, 245-259.
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 5.6.2.1 | 7-Ethyl-10-hydroxy-camptothecin | review of clinical pharmacokinetics | Mammalia |  |
| 5.6.2.1 | 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-camptothecin | i.e. irinotecan; review of clinical pharmacokinetics | Mammalia | |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 5.6.2.1 | Mammalia | - |
- |
- |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 5.6.2.1 | supercoiled DNA | relaxation | Mammalia | relaxed closed circular DNA | - |
? | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
